International trends in prostatic cancer
- 15 February 1984
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 33 (2) , 223-230
- https://doi.org/10.1002/ijc.2910330210
Abstract
The most recent data available demonstrate a 120‐fold difference between the lowest and highest incidence rates of prostatic cancer, the disease being very common in North America, particularly among Blacks, and in Scandinavia, while it is rare in Japan and other oriental countries. The highest mortality for prostatic cancer is reported from St. Vincent and Grenadines, Martinique and Bermuda, from countries where the morbidity statistics are not available; the mortality rates reported from the United States and Canada are considerably lower. The incidence of and mortality from prostatic cancer have increased in most countries, in particular in areas with an initially low frequency of this disease. The ratio of mortality to incidence for prostatic cancer varies rather widely, being low in North America, Hawaii and Scandinavia. It is suggested that the observed variation in the mortality to incidence ratio for prostatic cancer could be due to differences in diagnostic practices between countries. This could explain, at least in part, the fact that the increasing trends of prostatic cancer incidence in North America are not accompanied by an increase in mortality from this tumour. This notion, however, does not exclude advances in treatment as possible determinants of the improved survival rate from prostatic cancer in this part of the world. The available statistics on prostatic cancer are based on the sum of clinically diagnosed carcinomas and those latent tumours found unexpectedly at prostatectomy and autopsy. The proportion of latent carcinomas among all prostatic cancer cases depends on the detection rate and varies from country to country, thus casting uncertainty on the comparability of prostatic cancer statistics from different areas. To avoid confusion in the statistics of prostatic cancer, it would be useful to consider introducing latent prostatic cancer as a separate entity in the next revision of the International Classification of Diseases (ICD).This publication has 7 references indexed in Scilit:
- Cancer Patient Survival: Surveillance, Epidemiology, and End Results Program, 1973–79JNCI Journal of the National Cancer Institute, 1983
- Geographic pathology of latent prostatic carcinomaInternational Journal of Cancer, 1982
- Prevalence of Latent Prostate Carcinoma in Two U.S. Populations2JNCI Journal of the National Cancer Institute, 1980
- Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, FranceInternational Journal of Cancer, 1977
- Comparative Study of Latent Carcinoma of the Prostate Among Japanese in Japan and Hawaii 2JNCI Journal of the National Cancer Institute, 1973
- Cancer Incidence in Five ContinentsPublished by Springer Nature ,1970
- Cancer Incidence in Five ContinentsPublished by Springer Nature ,1966